SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-394410
Filing Date
2014-11-04
Accepted
2014-11-03 18:25:54
Documents
2
Period of Report
2014-10-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d812323d8k.htm 8-K 13031
2 EX-99.1 d812323dex991.htm EX-99.1 24550
  Complete submission text file 0001193125-14-394410.txt   38634
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 141190690
SIC: 2834 Pharmaceutical Preparations